Oratika (Zolpidem Tartrate)

Zolpidem tartrate, the active ingredient in Oratika, is a non‑benzodiazepine hypnotic presented as a tablet for oral use. It is indicated for the short‑term treatment of insomnia in adults.

GNH USA supplies Oratika as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oratika belongs to the non‑benzodiazepine hypnotic class and is used to manage sleep‑related disorders. - Insomnia: helps initiate and maintain sleep, improving total sleep time in adults. - Sleep onset insomnia: reduces the time needed to fall asleep. - Sleep maintenance insomnia: promotes longer uninterrupted sleep periods.

Adverse reactions to zolpidem are reported across a spectrum of frequency.

Common Side Effects: - Drowsiness or fatigue - Dizziness - Headache - Nausea - Unpleasant taste - Memory impairment (anterograde)

Serious or Rare Side Effects: - Complex sleep‑behaviour episodes (e.g., sleep‑walking, sleep‑driving) - Allergic reactions such as rash  de de de  de de  ewline -   ewline -    -  

Oratika should be taken . 

-   t   t  ewline -